| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FBXW7_0003800 | Intron-Intron | chr4:153267764-153268081 | chr4:152346612-152346929 | 318 nt | 0.3805 |
| hsa_FBXW7_0004200 | Exon-Exon | chr4:153268082-153268223 | chr4:152346930-152347071 | 142 nt | 0.5141 |
| hsa_FBXW7_0004300 | Exon-Exon | chr4:153268082-153303518 | chr4:152346930-152382366 | 403 nt | 0.4467 |
| hsa_FBXW7_0004000 | Exon-Exon | chr4:153268082-153333024 | chr4:152346930-152411872 | 795 nt | 0.4591 |
| hsa_FBXW7_0004400 | Exon-Exon | chr4:153268082-153333681 | chr4:152346930-152412529 | 845 nt | 0.4592 |
| hsa_FBXW7_0004500 | Intron-Exon-Intron | chr4:153268082-153391140 | chr4:152346930-152469988 | 225 nt | 0.4711 |
| hsa_FBXW7_0004100 | Intron-Exon-Intron | chr4:153268082-153403825 | chr4:152346930-152482673 | 250 nt | 0.3560 |
| hsa_FBXW7_0004600 | Intron-Exon-Intron | chr4:153271194-153271360 | chr4:152350042-152350208 | 167 nt | 0.3174 |
| hsa_FBXW7_0004700 | Intron-Intron | chr4:153278555-153278810 | chr4:152357403-152357658 | 256 nt | 0.4961 |
| hsa_chr4_0190600 | Intergenic-Intergenic | chr4:153278655-153280238 | chr4:152357503-152359086 | 1584 nt | 0.3428 |
A study in human brain cancer demonstrated that the circFBXW7 functions as a tumor suppressor, where its expression inhibits cell progression, migration, and tumor formation [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. Further research confirmed its coding potential, showing the translated peptide FBXW7-185aa reduces the half-life of c-Myc and inhibits cell cycle progression [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. The peptide FBXW7-185aa, which originates from the circFBXW7, inhibits cell cycle progression [Misir et al. DOI:10.1038/s41418-022-00948-7].